NewCardio, a Silicon Valley based company, has developed a novel, patented electrocardiography (ECG) platform technology to significantly improve the diagnostic accuracy and value of the standard 12 lead ECG for common acute and chronic heart disease.
| Jan 30 - 31, 2012. Alexandria, VA |
| CBI and Applied Clinical Trials 6th Annual Cardiovascular Risk Assessment Summit |